News Release [print friendly page]
FOR IMMEDIATE RELEASE
September 10, 2007
Special Agent Douglas S. Collier,
Public Information Officer
TEL: (973) 776-1143
CEL: (862) 849-9833

DEA New Jersey Division Hosts Pharmaceutical
Diversion Investigative Training Seminar
Event, in cooperation with the Middlesex County Prosecutor's
Office and the Rutgers University Police Department

WHO: The United States Department of Justice, Drug Enforcement Administration (DEA), in cooperation with the Middlesex County Prosecutor’s Office and the Rutgers University Police Department

WHAT: The Drug Enforcement Administration New Jersey Division is conducting a three day seminar on Pharmaceutical Diversion Investigations. This training program is designed to prepare police officers and other law enforcement officials with the ability to recognize specialized problems and contemporary issues associated with both the diversion of pharmaceutical controlled substances and federally regulated Chemicals. Topics which will be covered include DEA Diversion Program, Internet Pharmaceutical Diversion, Emerging Trends in Pharmaceutical use and abuse, Undercover Issues, and Methods for Diversion.

WHEN: September 11, 2007 – September 13, 2007

WHERE: Rutgers University, Cook Campus, 59 Biel Road, New Brunswick, New Jersey

WHY: Abuse of controlled prescription drugs is a major problem in the United States. According to a July, 2005 report from The National Center on Addiction and Substance Abuse (CASA) at Columbia University, the number of Americans who abuse controlled prescription drugs nearly doubled from 1992 to 2003 and abuse among teens more than tripled during that same time period. Americans abusing controlled prescription drugs exceed the number abusing cocaine, heroin, hallucinogens and inhalants, combined.

The mission of the Drug Enforcement Administration (DEA) is to enforce the controlled substances laws and regulations of the United States and bring to the criminal and civil justice system of the United States, or any other competent jurisdiction, those organizations and principal members of organizations, involved in the growing, manufacture, or distribution of controlled substances appearing in or destined for illicit traffic in the United States; and to recommend and support non-enforcement programs aimed at reducing the availability of illicit controlled substances on the domestic and international markets.